The company offers specialist reagents for live-cell imaging to research labs, as well as drug discovery and product development services to pharma and non-pharma companies. Their nanoparticle technology allows for effective delivery of therapeutic molecules, including those that can penetrate the blood-brain barrier. SomaServe also develops polyNaut technology for imaging live cells and creating bionic nanoparticles for drug release. Based in Cambridge, England.